Profound Medical Corp

PRN

Company Profile

  • Business description

    Profound Medical Corp is a commercial-stage medical device company focused on the development and marketing of AI-powered, MRI-guided, incision-free therapies for the ablation of diseased tissue. The company's flagship product, the TULSA-PRO system, combines real-time MRI, robotically-driven transurethral sweeping action/thermal ultrasound and closed-loop temperature feedback control to ablate whole gland or physician defined region of malignant or benign prostate tissue. Its platform technologies combine imaging, robotic control, and ultrasound-based thermal ablation for the treatment of prostate conditions. The company generates revenue through the sale of capital equipment and recurring sales of single-use devices and related services used in patient treatments.

  • Contact

    2400 Skymark Avenue
    Unit 6
    MississaugaONL4W 5K5
    CAN

    T: +1 647 476-1350

    E: [email protected]

    https://www.profoundmedical.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Medical Devices

    Fiscal Year End

    31 December 2026

    Employees

    162

Stocks News & Analysis

stocks

Why stocks sometimes fall for no obvious reason

How the private markets impact all equity investors.
stocks

Poor organic growth obscured by acquisition for ASX listed share

Sales dropped by 2% without impact of acquisition.
stocks

Nvidia dominance continues

Our view on the latest earnings report.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,877.2015.00-0.17%
CAC 408,135.8049.800.62%
DAX 4024,900.19293.421.19%
Dow JONES (US)50,565.59279.930.56%
FTSE 10010,468.5525.080.24%
HKSE25,606.03219.510.86%
NASDAQ26,491.30198.210.75%
Nikkei 22563,339.071,654.932.68%
NZX 50 Index12,991.31113.240.88%
S&P 5007,495.3449.620.67%
S&P/ASX 2008,657.0015.10-0.17%
SSE Composite Index4,112.9035.620.87%

Market Movers